NCT07518784Completed
Accurate Point of Care Liver Disease Diagnostics (Phase 2)
Accurate Point of Care Liver Disease Diagnostics
Source: ClinicalTrials.gov · Last updated 2 Nov 2026
Brief summary (registry, in English)
This research study is being conducted to find out more about techniques to non-invasively evaluate liver disease. This is the second phase of a project in which we are testing a new technology to evaluate the liver (LiverScope®). We will compare LiverScope® to other methods to evaluate the liver, including advanced conventional liver MR exams. MR exams are common exams used to monitor MASLD (also known as NAFLD). Conventional MR scanners use magnetic fields and radio waves to make pictures of the liver. LiverScope® is a small, portable MR-based device that uses similar, but simplified technology, and can be used on top of an exam table in an outpatient setting. LiverScope® currently is not approved for clinical use. In this second phase of the study, we took what we learned in the first phase to optimize the LiverScope® device and are now testing to see how LiverScope® measurements compare to MR after these optimizations. Study participants will be asked to complete a one-time visit which includes: * LiverScope exam * MR exam * FibroScan exam (optional) * Blood draw * Completion of study questionnaires
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 26 (actual)
- First submitted
- 1 Apr 2026
- Start date
- 8 Apr 2026
- Primary completion date
- 7 Aug 2026
- Lead sponsor
- University of California, San Diego
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT07518784
What you commit to
- Study type: Observational
- Participants enrolled: 26
- From 8 Apr 2026 to the primary completion date, 7 Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known chronic liver disease other than MASLD
Other
- UCSD study personnel or Livivos study personne
- Contraindications to MR
- Potential participant states that she knows that she is pregnant, thinks she may be pregnant, or states that she is trying to become pregnant.
Who the study is looking for
- Age ≥ 18 years
- Known or clinically suspected MASLD
- BMI greater than 27 kg/m\^2 and less than 45 kg/m\^2 at the time of referral
- Ability to lie on LiverScope® device table for about 60 minutes
- Ability to hold breath repeatedly for about 20 seconds during MR and LiverScope® exams
- Willing and able to undergo all study procedures
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of California San Diego Coordinator of this site? Confirm its status | La Jolla | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.